Sio Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-42,379
Closed -$3.94M 85
2021
Q4
$3.94M Buy
42,379
+20,641
+95% +$1.36M 1.19% 23
2021
Q3
$1.29M Hold
21,738
0.41% 50
2021
Q2
$1.48M Hold
21,738
0.37% 60
2021
Q1
$1.51M Sell
21,738
-36,000
-62% -$2.77M 0.31% 71
2020
Q4
$4.44M Sell
57,738
-14,015
-20% -$1.05M 0.91% 36
2020
Q3
$5.37M Sell
71,753
-23,400
-25% -$1.56M 1.06% 33
2020
Q2
$5.99M Buy
95,153
+10,000
+12% +$550K 1.75% 22
2020
Q1
$3.58M Sell
85,153
-4,204
-5% -$193K 1.2% 25
2019
Q4
$4.06M Buy
89,357
+45,500
+104% +$2.15M 0.97% 29
2019
Q3
$2.01M Buy
+43,857
New +$2.47M 0.65% 43
2017
Q4
Sell
-72,086
Closed -$1.84M 74
2017
Q3
$1.84M Buy
72,086
+2,734
+4% +$62.7K 0.95% 35
2017
Q2
$1.17M Buy
+69,352
New +$951K 0.56% 47

Sio Capital Management's ARNA Position: Q1 2022 in Review

Sio Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 42,379 shares — an estimated $3.94M sold.

Sio Capital Management first reported a position in ARNA in Q2 2017 and held it in 12 quarters. The position peaked at $5.99M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Sio Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Sio Capital Management sold 42,379 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.94M.
  • Sio Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 12 quarters.
  • Sio Capital Management's Arena Pharmaceuticals Inc position peaked at $5.99M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Sio Capital Management's 13F filing for Q1 2022, filed 16 May 2022.